| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.11B | 53.11B | 59.54B | 67.23B | 59.15B | 41.40B |
| Gross Profit | 3.48B | 3.39B | 4.84B | 3.68B | 3.36B | 2.79B |
| EBITDA | 2.90B | 2.46B | 4.02B | 2.88B | 3.23B | 2.11B |
| Net Income | 1.32B | 1.14B | 2.24B | 1.61B | 2.08B | 1.15B |
Balance Sheet | ||||||
| Total Assets | 46.30B | 24.90B | 25.37B | 24.58B | 23.82B | 23.66B |
| Cash, Cash Equivalents and Short-Term Investments | 3.72B | 3.79B | 2.71B | 1.22B | 1.42B | 698.00M |
| Total Debt | 17.78B | 7.12B | 5.76B | 5.62B | 6.82B | 8.10B |
| Total Liabilities | 29.01B | 13.95B | 13.56B | 14.62B | 15.61B | 17.04B |
| Stockholders Equity | 15.77B | 9.91B | 10.85B | 9.22B | 7.67B | 6.07B |
Cash Flow | ||||||
| Free Cash Flow | 61.00M | 524.00M | 2.19B | -6.10B | -3.29B | -3.90B |
| Operating Cash Flow | 550.00M | 1.90B | 3.31B | -5.55B | -2.89B | -3.54B |
| Investing Cash Flow | -5.68B | -1.11B | -1.01B | 6.50B | 5.11B | 1.81B |
| Financing Cash Flow | 3.56B | -90.00M | -856.00M | -769.00M | -1.63B | 1.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.84B | 3.34 | 55.20% | 10.53% | 65.80% | 197.95% | |
69 Neutral | $8.54B | 9.86 | ― | 4.44% | ― | ― | |
69 Neutral | $19.37B | 41.09 | 2.60% | 3.48% | 2.12% | -40.75% | |
66 Neutral | $18.25B | 10.14 | 10.24% | 3.14% | 10.29% | 17.32% | |
64 Neutral | $29.07B | 24.61 | 5.35% | 3.55% | -4.31% | -29.96% | |
64 Neutral | $1.68B | 21.42 | 3.95% | 3.34% | 1.11% | 414.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Effective December 16, 2025, Bunge Global SA reduced its share capital by USD 123,826.10, from USD 2,208,943.73 to USD 2,085,117.63, following the cancellation of 12,382,610 repurchased registered shares with a nominal value of $0.01 per share as part of its share repurchase program. In connection with this capital reduction, the company also amended Article 4a of its Articles of Association to update its Swiss capital band provision, formalizing the changes to its equity structure and governance framework.
The most recent analyst rating on (BG) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.
On December 12, 2025, Bunge Global SA announced the departure of David Mattiske from his role as co-Chief Operating Officer to explore other professional opportunities. Julio Garros, currently serving as co-Chief Operating Officer, will take over as Chief Operating Officer starting December 12, 2025, ensuring a smooth transition of responsibilities.
The most recent analyst rating on (BG) stock is a Hold with a $99.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.
Bunge Global has released a current report on Form 8-K, which is a standard form used by publicly traded companies to disclose significant events that shareholders should know about. The report’s content, however, is not detailed in the provided text, leaving the specific impact on Bunge Global’s operations, industry positioning, or implications for stakeholders unclear.
The most recent analyst rating on (BG) stock is a Hold with a $99.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.
On October 15, 2025, Bunge Global SA announced changes to its segment and volume reporting to align with its new value chain structure following its merger with Viterra Limited. The company realigned its operations into new segments and updated its full-year 2025 earnings outlook, reflecting the merger’s impact and providing a clearer understanding of its financial performance.
The most recent analyst rating on (BG) stock is a Buy with a $92.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.
Bunge Global has terminated several significant credit agreements, including a $3.2 billion revolving credit agreement, a $1.1 billion 364-day revolving credit agreement, and a $3.5 billion revolving agreement. This decision may impact the company’s financial strategy and liquidity management, potentially affecting its operations and market positioning.
The most recent analyst rating on (BG) stock is a Buy with a $91.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.